A Competition Commission probe led to the dropping of a patent on a key tuberculosis medicine in South Africa. Twenty years ago, a similar case reduced antiretroviral prices, aiding the HIV treatment programme. Fatima Hassan and Leena Menghaney compare these landmark cases and highlight changes over the past two decades.
